Pharmacy Practice Report
Pharmacy Practice Report
In association with
AGRAWAL HOSPITAL,AHMEDNAGAR
Submitted to
Savitribai Phule Pune University
Submitted by
RAMESHWAR ASHOK SHINDE
( T.Y. B. PHARMACY)
(A.Y – 2022-23)
⚫ Forecast of demand
⚫ Selection of reliable suppliers
• Prescribing specifications of the required medicament Manufacturing of
sterile or non-sterile preparations
• Maintenance of manufacturing records Quality control of purchased or
manufactured products
⚫ Distribution of medicaments in the wards
⚫ Dispensing of medicaments to out-patients
⚫ Drug information source in hospitals
⚫ Centre for drug utilization studies
⚫ Implement recommendations of the pharmacy and therapeutic
committee
⚫ Patient counseling
One of the key themes of the 2010 White Paper is empowering patients
to take an active role in managing their own care. This is also one of the
themes of many of the NHS National Institute for Health Research
collaborations for leadership in applied health research and care that
focus on translating research into practice. Helping patients to
understand their medicines and how to take them is a major feature of
clinical pharmacy. Patient compliance, defined as adherence to the
regimen of treatment recommended by the doctor, has been a concern
of healthcare professionals for some time. Adherence to treatment,
particularly for long-term chronic conditions, can be poor and tends to
worsen as the number of medicines and complexity of treatment
regimens increase. NICE noted that between a third and half of all
medicines prescribed for long term conditions are not taken as
recommended and estimated that the cost of admissions resulting from
patients not taking medicines as recommended was between £36 million
and £196 million in 2006-2007.
The fact that not all patients respond to the expected benefits of
medicines and some have disproportionately adverse effects from them
is leading to the development of personalised medicines services. Good
clinicians have always tailored treatment to individual patients' needs,
but this typically relied on trial and error. Personalised medicine can start
from using biomarkers rather than clinical outcomes as surrogate
markers of effectiveness and a new specialty of pharmacogenetics that
aims to assess phenotypic differences in responding to and handling
drugs that may account for a proportion of the variation in patient
response. A Parliamentary Office of Science and Technology review
noted that:
3. Research work.
Pharmacists' Responsibilities.
Dispense Prescriptions.
Counsel Patients.
Manage Staff.
4. Preparation of bills
5. Counseling patients
4. Preparation of bills
3. Monitoring of drugs